Locations:
SearchLearn about featured cancer clinical trials currently enrolling, or search our cancer clinical trials database for all open and accruing studies.
Renal
A Phase II study of the efficacy and safety of Axitinib given on an individualized schedule for metastatic renal cell cancer after treatment with PD-1 or PD-l1 inhibitor
CASE 7815
View full trial information.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Leukemia, Chronic Myelomonocytic (CMML)
A Phase 2 Study of Tipifarnib in Subjects with Chronic Myelomonocytic Leukemia
KURA 1916
View full trial information.
Paroxysmal Nocturnal Hemoglobinuria (PNH)
A Phase 3, Randomized, Open-Label, Active-Controlled Study of ALXN1210 Versus Eculizumab in Complement Inhibitor-Naïve Adult Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
ALEX 1Z16
View full trial information.
Lymphoma
p53/p16-Independent Epigenetic Therapy with Oral Decitabine/Tetrahydrouridine for Refractory/Relapsed Lymphoid Malignancies
CASE 1416
View full trial information.
Search our Cancer Clinical Trials Database for a full listing of all open and accruing studies.
Advertisement
Advertisement
First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses
Global R&D efforts expanding first-line and relapse therapy options for patients
Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels
A case study on the value of access to novel therapies through clinical trials
Findings highlight an association between obesity and an increased incidence of moderate-severe disease
Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456
Key learnings from DESTINY trials
Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients